Skip to content

Chapter 25: Monopoly — The Good, the Bad, and the Ugly

Core idea

“Monopoly” is not a synonym for “bad.” Some monopolies are required by the structure of the underlying market (one electrical grid serves a city more cheaply than five competing grids ever could). Others are granted by the government to encourage behavior we want (patents, copyrights, certain public services). The problem is unregulated monopoly — a sole seller with no competition, no price ceiling, and no obligation to serve. The chapter divides the world into three buckets: the good (natural monopolies + patent / technological monopolies), the bad-ish (government monopolies, where philosophical disagreement is genuine), and the ugly (pure unregulated monopoly, like De Beers at its peak).

Authors’ framing: When monopoly is allowed to exist, it’s for a good reason. But even the good ones need watching — and the ugly ones, history shows, need breaking up.

Why it matters

The reflex “monopoly = evil → break it up” is wrong often enough to make policy worse, not better. A more useful frame: ask why the monopoly exists, then choose a response that fits.

Natural monopoly: when one is cheaper than many

Some industries have such large economies of scale that average cost keeps falling as the firm gets bigger. Power generation, water distribution, fiber-to-the-home, freight rail, and pipeline networks all fit. If you forced “competition” by allowing five separate companies to dig up the same streets and run parallel infrastructure, the total cost would be much higher than the cost of letting one firm do it. The right answer here isn’t antitrust — it’s price regulation: let the natural monopoly capture the scale economies, but regulate the price it can charge.

Technological monopoly: temporary by design

When a firm invents something genuinely new, the patent system grants it a 20-year monopoly on that invention. The price is high; the social trade-off is that without the monopoly, no one would invest the billions to develop the next cancer drug. The patent is a deliberate distortion: pay monopoly prices for two decades so that the pipeline of inventions stays full. After the patent expires, generics enter and the price collapses. This is good monopoly because it’s bounded — temporary and contingent on doing something useful.

Unregulated monopoly: the ugly case

A firm that achieves true single-seller status with no patent, no scale rationale, and no government grant — usually by buying up competitors or controlling a key input — has every incentive to raise prices, suppress quality, and block new entrants. Standard Oil, De Beers, and (arguably) some modern platform companies all fit. The remedy here is structural: break up, force interoperability, or impose conduct rules. Doing nothing means consumers pay the monopoly tax forever.

Key takeaways

Key takeaways

  • Monopoly = a market with a single seller. The US generally prohibits monopolies; the FTC and DOJ enforce antitrust law to prevent their creation.
  • Four legitimate reasons monopolies exist: economies of scale (natural monopoly), patents (technological monopoly), government mandate, and geographic isolation.
  • Natural monopoly: when average cost falls with size so much that one large producer is cheaper than several smaller ones (utilities, pipelines, rail). Regulated, not broken up.
  • Technological monopoly: patents grant a 20-year monopoly on an invention. The high prices fund R&D; after expiration, competitors enter and prices fall.
  • Government monopoly (USPS, federal agencies): exists for non-economic reasons. Whether it should be preserved or privatized is mostly a political question, not an economic one.
  • Pure unregulated monopoly is harmful: high prices, low output, no innovation pressure, massive barriers to entry. Sherman Antitrust Act (1890) was the response.
  • De Beers diamonds is the canonical 'ugly' monopoly — a century of artificial scarcity creating profits unrelated to actual production cost.
  • The right policy response depends on which type of monopoly you have. Breaking up a natural monopoly raises costs; failing to regulate an unregulated one cements them.

Mental model — the four kinds of monopoly

Read it as: Don’t ask “is this a monopoly?” — ask “why is this a monopoly?” Natural and technological monopolies (green) are defensible because the alternative is worse: higher costs or fewer inventions. Government monopolies (purple) are a values choice. Only the bottom-right path (red) — a monopoly with no scale rationale, no patent, no public mandate — is unambiguously bad, and that’s the category antitrust law was built to attack.

Mental model — the unregulated monopoly playbook

Practical application

Diagnose monopolies before judging them

Spot the warning signs of a tipping monopoly

  1. Acquisition patterns. A firm buying up small competitors — especially nascent ones — before they grow is a classic tell. (Facebook/Meta’s purchase of Instagram and WhatsApp is the case currently in court.)

  2. Exclusive dealing. Suppliers or distributors being told “work with us or lose access to our platform” suggests leverage being used to extend dominance.

  3. Predatory pricing. Below-cost pricing to drive out a competitor, then raising prices once the competitor exits.

  4. Self-preferencing. A platform that runs both the marketplace and competes against sellers on it (Amazon’s private-label products vs. third-party sellers) sits in the antitrust crosshairs.

  5. Switching costs that look engineered. Lock-in mechanisms — non-portable data, proprietary formats, contract terms that punish leaving — often signal a firm trying to convert market position into permanent monopoly.

Example: three monopolies, three correct responses

Imagine you’re a regulator facing three cases on the same day.

Case 1: City Water Utility. Provides 100% of drinking water to a metropolitan area of 2 million. Pipes are sunk in every street. Splitting the company into five competing utilities would require five parallel pipe networks — financially absurd. Right response: keep the single utility. Regulate its rate of return (typically 8-12% on invested capital). Mandate service quality standards. This is exactly how most US water and electric utilities operate.

Case 2: PharmaCo’s new cancer drug. PharmaCo spent $2.3 billion developing the drug. It’s the only one of its kind. They charge $14,000/month. Patent runs 20 years from filing; with development time, about 12 years of monopoly remain. Right response: let the patent run. Generic competition after expiration will drop the price by 80-95% within a few years. Without the patent, the drug wouldn’t exist at all. Negotiate Medicare prices and subsidize uninsured access in the meantime — but don’t strip the patent.

Case 3: SocialApp. Has 87% of the social-networking market. Acquired its three biggest rivals before they could threaten it. Charges advertisers monopoly rates and has minimal product improvements in five years. No scale rationale (the underlying technology runs fine at any scale), no patent monopoly, no government mandate. Right response: antitrust action. Investigate the acquisitions. Consider structural separation (force-spin the acquired companies back into independence). Impose interoperability requirements so users can leave without losing their network.

Same word — monopoly — three completely different correct policies.

Caveats

Jump to…

Type to filter; press Enter to open